Varicella Zoster Virus ORF9 recombinant antigen
Product Description: VZV ORF9 antigen (recombinant). VZV a.a. 6-28; a.a. 76-100 of the ORF9 immunodominant region.
Fusions: GST at N-terminus
Origin: E. coli, recombinant
Purity: >90% pure; Purity of proteins is evaluated by SDS-PAGE and by method of Bradford et al.
Buffer/Composition: 60 mM NaCl; 50 mM Tris-HCl pH 8.0; 0.25% Sarkosil; 50% Glycerol; 10 mM glutathione.
Concentration: 1 mg/ml, bulk amount available upon request
Storage: Long Term: -80˚C
Short Term: 4˚C (Three month or less)
Application: ELISA, WB, Flow-through
Comments: Strongly reacts with human VZV positive serum
The products are for laboratory research use or further manufacturing only and should not be used for human therapeutic or diagnostic applications.